Michelle Fredrika Forshager

Title: **The Innovative Contributions of Michelle Fredrika Forshager**

Introduction

Michelle Fredrika Forshager is an accomplished inventor based in Vancouver, WA. She has made significant contributions to the field of diagnostic technology, holding two patents that showcase her expertise in automated diagnostic systems for allergies and autoimmune diseases.

Latest Patents

Michelle's latest patents include an advanced automated immunoanalyzer system that performs diagnostic assays for allergies and autoimmune diseases. This innovative invention involves a quantitative method that consists of multiple steps: incubating a capture reagent with a streptavidin-coated medium to form a solid phase complex, washing the complex to remove excess capture reagent, and then incubating it with a serum sample to form an immune complex. The process continues with further washing, followed by incubation with a conjugate to create an immune-conjugate complex, and additional washing to eliminate any unbound conjugate. The final step involves introducing a substrate capable of generating a quantifiable response, and calibrating that response to ensure accuracy in diagnostics.

Career Highlights

Michelle currently works at Hycor Biomedical, LLC, where she develops innovative diagnostic solutions. Her role at the company has positioned her as a key player in advancing medical technology who is committed to improving patient care through her inventions.

Collaborations

Throughout her career, Michelle has collaborated with talented professionals, including her coworkers Mark David Van Cleve and Taylor Reid. Their combined efforts contribute to the research and development of groundbreaking technologies that enhance diagnostic practices.

Conclusion

Michelle Fredrika Forshager's work in the field of diagnostics reflects her dedication to innovation and her ability to create solutions that address critical health issues. Her patents not only signify her prowess as an inventor but also highlight the importance of collaboration in the realm of medical advancements. As she continues her work at Hycor Biomedical, her contributions will undoubtedly lead to further innovations in the healthcare industry.